{
    "organizations": [],
    "uuid": "c15792eeadc7e09be9f2dd85d32617fa5633147c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-azurrx-biopharma-enrolls-new-patie/brief-azurrx-biopharma-enrolls-new-patients-for-phase-iia-study-of-ms1819-sd-idUSFWN1Q2122",
    "ord_in_thread": 0,
    "title": "BRIEF-Azurrx Biopharma Enrolls New Patients For Phase IIA Study Of MS1819-SD",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 21 PM / in 13 minutes BRIEF-Azurrx Biopharma Enrolls New Patients For Phase IIA Study Of MS1819-SD Reuters Staff 1 Min Read \nFeb 12 (Reuters) - Azurrx Biopharma Inc: \n* AZURRX BIOPHARMA ANNOUNCES ENROLLMENT OF THREE NEW PATIENTS FOR ITS PHASE IIA STUDY OF MS1819-SD Source text for Eikon:  ",
    "published": "2018-02-12T15:20:00.000+02:00",
    "crawled": "2018-02-12T15:47:55.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "biopharma",
        "enrolls",
        "new",
        "patient",
        "phase",
        "iia",
        "study",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "azurrx",
        "biopharma",
        "inc",
        "azurrx",
        "biopharma",
        "announces",
        "enrollment",
        "three",
        "new",
        "patient",
        "phase",
        "iia",
        "study",
        "source",
        "text",
        "eikon"
    ]
}